+86-28-82633987sales@biopurify.com
Batch Search
Alternate Text
Home > Product Category > Compound Types > Phenols

Curcumin

CAS No.:458-37-7

Curcumin
Catalogue No.: BP0421
Formula: C21H20O6
Mol Weight: 368.385
Botanical Source: Curcuma Longa L.
Contacts
+86-28-82633860  +86-18080483897
 
Email: sales@biopurify.com biopurify@gmail.com

Curcumin

CAS No.:458-37-7

Curcumin
Catalogue No.: BP0421
Formula: C21H20O6
Mol Weight: 368.385
Botanical Source: Curcuma Longa L.
Contacts
+86-28-82633860  +86-18080483897
 
Email: sales@biopurify.com biopurify@gmail.com
Over 15 years of industry experience in phytochemicals from R&D(reference substances) to Industrialization, please feel free to contact us!


Product name: Curcumin
Synonym name: Diferuloylmethane
Catalogue No.: BP0421
Cas No.: 458-37-7
Formula: C21H20O6
Mol Weight: 368.385
Botanical Source: Curcuma zedoaria, other Curcuma spp. and other spp.
Physical Description: Orange powder
Type of Compound: Phenols

Purity: 95%~99%
Analysis Method: HPLC-DAD or/and HPLC-ELSD
Identification Method: Mass, NMR
Packing: Brown vial or HDPE plastic bottle

Storage: Store in a well closed container, protected from air and light. Put into refrigerate or freeze for long term storage.
Whenever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20℃. Generally, these will be useable for up to two weeks.

The product could be supplied from milligrams to grams, up to kilograms
Inquire for bulk scale.

Descriptions:
Curcumin, a polyphenolic compound derived from dietary spice turmeric, possesses diverse pharmacologic effects including anti-inflammatory, antioxidant, antiproliferative and antiangiogenic activities, it has effective activity against including cancer, cardio-
vascular diseases, diabetes, arthritis, neurological diseases and Crohn's disease; it is safe even at high doses (12 g/day) in humans but exhibits poor bioavailability, to improve its bioavailability , numerous approaches have been undertaken, such as, first, the use of adjuvant like piperine that interferes with glucuronidation; second, the use of liposomal curcumin; third, curcumin nanoparticles; fourth, the use of curcumin phospholipid complex; and fifth, the use of structural analogues of curcumin (e.g., EF-24). [1,2]
Curcumin is reported against leukemia and lymphoma, gastrointestinal cancers, genitourinary cancers, breast cancer, ovarian cancer, head and neck squamous cell carcinoma, lung cancer, melanoma, neurological cancers, and sarcoma reflects its ability to affect multiple targets, shows to interfere with multiple cell signaling pathways, including cell cycle (cyclin D1 and cyclin E), apoptosis (activation of caspases and down-regulation of antiapoptotic gene products), proliferation (HER-2, EGFR, and AP-1), survival (PI3K/AKT pathway), invasion (MMP-9 and adhesion molecules), angiogenesis (VEGF), metastasis (CXCR-4) and inflammation (NF-κB, TNF, IL-6, IL-1, COX-2, and 5-LOX). [3]
Curcumin has anti-inflammation activity, can regulate numerous transcription factors, cytokines, protein kinases, adhesion molecules, redox status and enzymes that have been linked to inflammation, has been shown to play a major role in most chronic illnesses, including neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.[4]

References:
[1] Anand P, Kunnumakkara A B, Newman R A, et al. Mole Pharm, 2007, 4(6):807-18.
[2] Duvoix A, Blasius R, Delhalle S, et al. Cancer Lett, 2005, 223(2):181-190.
[3] Preetha Anand, Chitra Sundaram, Sonia Jhurani, et al.Cancer Lett, 2008, 267(1):133-64.
[4] Aggarwal B B, Harikumar K B. Int J Biochem Cell B, 2009, 41(1):40-59.
[5] Jadhav B K, Mahadik K R, Paradkar A R. Chromatographia, 2007, 65(7):483-8.


HPLC of Curcumin